Literature DB >> 2486527

The indeterminate form of human chronic Chagas' disease A clinical epidemiological review.

J C Dias.   

Abstract

Data on the epidemiology and the natural history of the indeterminate form of human chronic Chagas' disease (IFCCD) are discussed, revealing its great importance in endemic areas of Brazil. The work shows that IFCCD presents a gradual and very slow course, causing a benign picture in the studied patients. Evolution patterns, prognostic and anatomo-pathological features are also discussed. For practical purposes, the classical concept of IFCCD proved to be simple, operational and consistent. It is defined by the absence of symptoms and clinical findings in chronic infected patients with positive serology and/or parasitological examinations for Trypanosoma cruzi coupled with normal electrocardiographic and radiological exams (heart, oesophagus and colon X-Rays). If a patient is submitted to more rigorous and sophisticated tests, these can reveal some alterations, generally small ones and unable to interfere with the prognosis of the infection. It is suggested that research lines specially related to the evolutionary factors and immunological involvement during this phase be adopted.

Entities:  

Mesh:

Year:  1989        PMID: 2486527     DOI: 10.1590/s0037-86821989000300007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  26 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.

Authors:  Juliana A S Gomes; Lilian M G Bahia-Oliveira; Manoel Otávio C Rocha; Solange C U Busek; Mauro M Teixeira; João Santana Silva; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response.

Authors:  J A S Gomes; L M G Bahia-Oliveira; M O C Rocha; O A Martins-Filho; G Gazzinelli; R Correa-Oliveira
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

5.  Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.

Authors:  Vladimir Michailowsky; Keith Luhrs; Manoel Otávio C Rocha; David Fouts; Ricardo T Gazzinelli; Jerry E Manning
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Major cysteine protease (cruzipain) in Z3 sylvatic isolates of Trypanosoma cruzi from Rio de Janeiro, Brazil.

Authors:  S A O Gomes; D Misael; B A Silva; D Feder; C S Silva; T C M Gonçalves; A L S Santos; J R Santos-Mallet
Journal:  Parasitol Res       Date:  2009-05-13       Impact factor: 2.289

7.  Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.

Authors:  Gilberto M Sperandio da Silva; Mayara C Chambela; Andrea S Sousa; Luiz Henrique C Sangenis; Sergio S Xavier; Andréa R Costa; Pedro Emmanuel A A Brasil; Alejandro M Hasslocher-Moreno; Roberto M Saraiva
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

Review 8.  Regulatory T cells phenotype in different clinical forms of Chagas' disease.

Authors:  Fernanda Fortes de Araújo; Danielle Marquete Vitelli-Avelar; Andréa Teixeira-Carvalho; Paulo Renato Antas; Juliana Assis Silva Gomes; Renato Sathler-Avelar; Manoel Otávio Costa Rocha; Silvana Maria Elói-Santos; Rosa Teixeira Pinho; Rodrigo Correa-Oliveira; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

9.  Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.

Authors:  Clara Crespillo-Andújar; Emmanuele Venanzi-Rullo; Rogelio López-Vélez; Begoña Monge-Maillo; Francesca Norman; Ana López-Polín; José A Pérez-Molina
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.228

10.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.